For instance, CEA and CA 19-9 were both described only in one RCT [13] which talked about pancreatobiliary cancer, while PSA was shown in another RCT [25] for prostate cancer and with no other comparison. This evidence concerns the gene KLK3 and Familial prostate cancer.